How new tobacco products and additives affect young people's smoking habits
Impact of new tobacco product design and synthetic additives on use initiation and preference behavior
This study is looking at how new tobacco products, like oral nicotine pouches and non-menthol cigarettes, affect young people’s choices and habits around smoking, especially focusing on what makes these products appealing and how they might lead to addiction.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10946942 on NIH RePORTER |
What this research studies
This research investigates the impact of new tobacco products, specifically oral nicotine pouches and non-menthol cigarettes, on the initiation and preference behaviors of adolescents and young adults. The study will analyze how the design and formulation of these products, including their flavors and additives, influence nicotine intake and addiction. By examining the chemical composition and behavioral effects of these products, the research aims to understand their appeal to younger consumers and the potential risks associated with their use. Participants may be asked to provide feedback on their experiences with these products and their perceptions of nicotine consumption.
Who could benefit from this research
Good fit: Ideal candidates for participation include adolescents and young adults under 21 who are current users or have experience with tobacco products.
Not a fit: Patients who are over 21 years old or have never used tobacco products may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better regulations and public health strategies to prevent nicotine addiction among young people.
How similar studies have performed: Previous research has shown that understanding product design and consumer behavior can effectively inform public health policies, making this approach promising.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Jordt, Sven-Eric — Duke University
- Study coordinator: Jordt, Sven-Eric
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.